Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:LOGC NYSE:MYTE NYSE:OG NYSE:VGII On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeLOGCLogicBio Therapeutics$8.91+0.1%$8.93$6.82▼$10.35$407M2.01159,752 shs63,804 shsMYTEMYT Netherlands Parent B.V.$7.43-0.9%$7.81$7.55▼$8.50$636.74M1.08172,407 shs114,677 shsOGOnion Global$0.00$0.00$0.19▼$2.80$32K-3.42490,801 shsN/AVGIIVirgin Group Acquisition Corp. II$1.25-2.3%$1.21$5.70▼$9.99$62.89MN/A141,126 shs37,346 shs7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceLOGCLogicBio Therapeutics+1.37%+3.60%-1.55%+8.66%+30.84%MYTEMYT Netherlands Parent B.V.-0.93%-2.62%+5.69%-7.13%-6.42%OGOnion Global0.00%+50.00%+50.00%+50.00%+50.00%VGIIVirgin Group Acquisition Corp. II-2.34%+2.46%+6.84%-2.34%+8.70%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeLOGCLogicBio Therapeutics$8.91+0.1%$8.93$6.82▼$10.35$407M2.01159,752 shs63,804 shsMYTEMYT Netherlands Parent B.V.$7.43-0.9%$7.81$7.55▼$8.50$636.74M1.08172,407 shs114,677 shsOGOnion Global$0.00$0.00$0.19▼$2.80$32K-3.42490,801 shsN/AVGIIVirgin Group Acquisition Corp. II$1.25-2.3%$1.21$5.70▼$9.99$62.89MN/A141,126 shs37,346 shs7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceLOGCLogicBio Therapeutics+1.37%+3.60%-1.55%+8.66%+30.84%MYTEMYT Netherlands Parent B.V.-0.93%-2.62%+5.69%-7.13%-6.42%OGOnion Global0.00%+50.00%+50.00%+50.00%+50.00%VGIIVirgin Group Acquisition Corp. II-2.34%+2.46%+6.84%-2.34%+8.70%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceLOGCLogicBio Therapeutics 0.00N/AN/AN/AMYTEMYT Netherlands Parent B.V. 0.00N/AN/AN/AOGOnion Global 0.00N/AN/AN/AVGIIVirgin Group Acquisition Corp. II 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookLOGCLogicBio Therapeutics$43M9.48N/AN/A$4.95 per share1.80MYTEMYT Netherlands Parent B.V.$881.44M0.72N/AN/A$5.19 per share1.43OGOnion Global$2.04B0.00N/AN/A$1.48 per share0.00VGIIVirgin Group Acquisition Corp. IIN/AN/A$0.01 per share111.14($0.59) per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateLOGCLogicBio Therapeutics-$29M-$1.09N/AN/AN/AN/A-1.73%-1.22%8/6/2026 (Estimated)MYTEMYT Netherlands Parent B.V.-$26.95M-$0.43N/A92.88N/A-3.98%-5.88%-3.63%N/AOGOnion Global-$55.90MN/AN/AN/AN/AN/AN/AN/AN/AVGIIVirgin Group Acquisition Corp. II$2.70MN/AN/AN/AN/AN/A-22.81%-4.99%N/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthLOGCLogicBio TherapeuticsN/AN/AN/AN/AN/AMYTEMYT Netherlands Parent B.V.N/AN/AN/AN/AN/AOGOnion GlobalN/AN/AN/AN/AN/AVGIIVirgin Group Acquisition Corp. IIN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioLOGCLogicBio Therapeutics0.281.671.15MYTEMYT Netherlands Parent B.V.0.091.780.22OGOnion GlobalN/AN/AN/AVGIIVirgin Group Acquisition Corp. IIN/A0.180.18Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipLOGCLogicBio Therapeutics46.05%MYTEMYT Netherlands Parent B.V.10.07%OGOnion Global2.58%VGIIVirgin Group Acquisition Corp. II93.36%Insider OwnershipCompanyInsider OwnershipLOGCLogicBio Therapeutics42.47%MYTEMYT Netherlands Parent B.V.1.90%OGOnion Global50.90%VGIIVirgin Group Acquisition Corp. IIN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableLOGCLogicBio Therapeutics6245.73 million26.31 millionNo DataMYTEMYT Netherlands Parent B.V.1,24085.70 million83.65 millionNo DataOGOnion Global796105.12 million51.61 millionNot OptionableVGIIVirgin Group Acquisition Corp. IIN/A50.31 millionN/ANot OptionableLOGC, MYTE, VGII, and OG HeadlinesRecent News About These CompaniesVirgin Music Group acquires Downtown Music Holdings for $775 millionDecember 17, 2024 | msn.comVirgin Music Group Acquires Beijing-Based Outdustry, Adds Founder Ed Peto As International Strategy HeadNovember 1, 2024 | msn.comA Deeper Look At The Virgin America SaleOctober 30, 2024 | msn.comDarwin Airport group says Qatar-Virgin acquisition spells good news for Top EndOctober 5, 2024 | couriermail.com.auCJT Group to Acquire Vector Group in Deal Valued at $2.4BAugust 26, 2024 | csnews.comCThe history of Virgin Atlantic: How a record executive took on the airline establishment and won.July 26, 2024 | msn.comNationwide’s £2.9bn swoop on Virgin Money gets go-ahead from CMAJuly 20, 2024 | msn.comNationwide CEO: No plans for more big acquisitions after £2.9bn Virgin Money dealMay 23, 2024 | msn.comBritain's Nationwide eyes near $2 billion gain on Virgin Money dealMay 23, 2024 | msn.comRichard Branson: Virgin founder’s net worth gets a boost from Virgin Atlantic’s growthMay 19, 2024 | msn.comVirgin Money faces potential shareholder revolt over £2.9bn Nationwide dealMay 14, 2024 | msn.comSeiko Group Corp.March 28, 2024 | wsj.comSavvas Learning Company Named to the 2024 GSV 150 of Top-Growth CompaniesMarch 12, 2024 | eschoolnews.comEHow Nationwide’s Acquisition of Virgin Money Will Influence the UK Banking SectorMarch 9, 2024 | msn.comNationwide acquisition of Virgin Money expected to push up its fundingMarch 7, 2024 | globalcapital.comGNationwide swoops on Virgin Money in controversial £2.9 billion dealMarch 7, 2024 | msn.comViveon Health Acquisition receives NYSE American notice for delistingDecember 27, 2023 | msn.comYEAR IN REVIEW: R-V Industries committed to strategic ‘growth through acquisition’December 26, 2023 | pottsmerc.comPBowen Acquisition Corp BOWNDecember 19, 2023 | morningstar.comMVirgin Group Acquisition Corp. II Redeemable Warrants each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50December 4, 2023 | thestreet.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeLOGC, MYTE, VGII, and OG Company DescriptionsLogicBio Therapeutics OTCMKTS:LOGC$8.91 +0.01 (+0.11%) As of 07/1/2026 03:58 PM EasternLogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is an adeno-associated virus, which is designed to optimize gene delivery for treatments in a range of indications and tissues. Its lead product candidate is LB-001 that is in Phase I/II clinical trials for the treatment of methylmalonic acidemia. The company has a collaboration with Children's Medical Research Institute to develop next-generation capsids for gene therapy and gene editing applications in the liver, as well as additional tissues; and a collaboration agreement with Takeda Pharmaceutical Company Limited to develop LB-301, an investigational therapy for the treatment of Crigler-Najjar syndrome. The company also has a research collaboration, license, and option agreement with CANbridge Care Pharma Hong Kong Limited; and collaboration agreement with Daiichi Sankyo Company. The company was incorporated in 2014 and is headquartered in Lexington, Massachusetts.MYT Netherlands Parent B.V. NYSE:MYTE$7.43 -0.07 (-0.93%) As of 06/30/2026MYT Netherlands Parent B.V., through its subsidiary, Mytheresa Group GmbH, operates a luxury e-commerce platform for fashion consumers in Germany, the United States, rest of Europe, and internationally. It offers womenswear, menswear, kids wear, and lifestyle products. The company sells clothes, bags, shoes, accessories, and fine jewelry through online and retail stores. It serves high-income luxury consumers. The company was founded in 1987 and is based in Munich, Germany.Onion Global NYSE:OG$0.0003 0.00 (0.00%) As of 06/30/2026Onion Global Limited operates a platform that incubates, markets, and distributes fashionable and future brands in China and internationally. Its platform comprises brand partners that offer various categories of lifestyle products, including beauty products, maternal and baby products, food and beverages, fast fashion, and wellness products. The company was incorporated in 2009 and is based in Guangzhou, the People's Republic of China.Virgin Group Acquisition Corp. II NYSE:VGII$1.25 -0.03 (-2.34%) As of 06/30/2026Virgin Group Acquisition Corp. II does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. Virgin Group Acquisition Corp. II was incorporated in 2021 and is based in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Uber’s Waymo Detour Tests the Stock’s Robotaxi Bull Case Copper Stocks Are Getting a Bigger Spotlight as Gold’s Rally Cracks AirJoule Unveils Prime System, Clearing Path to Commercialization Comcast’s NBCUniversal Split Puts Broadband Back in Focus Nike Q4 Beat Masks Core Weakness as Analysts Cut Price Targets Ouster Is Breaking Out as a Physical AI Leader: Here's What's Driving the Move Meta’s WhatsApp Shakeup Could Put India at the Center of Its Next Growth Push Hershey Stock May Be Near a Sweet Spot as Cocoa Pressure Eases Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
